MedTrace Logo

Effectiveness of Telephysical Therapy as a Secondary Stroke Prevention Tool in Patients With Minor Stroke.

NCT06780891 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2025-05-28

No results posted yet for this study

Summary

This study investigates the effectiveness of telephysiotherapy as a rehabilitation and secondary prevention tool in patients with minor stroke, TIA, or LACI, comparing an experimental group receiving tele-assisted aerobic and anaerobic exercises to a control group.

Conditions

  • Stroke
  • Physical Therapy Modality
  • Secondary Prevention
  • Physical Therapy Evaluation
  • Therapeutic Exercise
  • Randomized Controlled Trial
  • Cerebrovascular Accident (Stroke)

Interventions

BEHAVIORAL

Telephysical therapy

The experimental group is undergoing a tele-assisted therapeutic exercise program (T-TPT/T-FIS), which involves physical exercises aimed at improving cardiovascular fitness, muscle strength, and balance, among others. Participants will complete exercises under virtual supervision and submit progress reports.

BEHAVIORAL

Educational session

The educational session will focus on raising awareness about stroke risk factors, such as hypertension, diabetes, and smoking, while promoting healthy lifestyle changes. The goal is to empower them with the knowledge to reduce stroke risk and improve overall well-being.

Sponsors & Collaborators

  • Hospital Universitario Virgen Macarena

    collaborator OTHER

  • University of Cadiz

    lead OTHER

Principal Investigators

  • David Manuel Lucena Antón, Doctor of PT · University of Cadiz

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-14
Primary Completion
2025-03-31
Completion
2025-05-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06780891 on ClinicalTrials.gov